Skip to main content
Top
Published in: BMC Infectious Diseases 1/2023

Open Access 01-12-2023 | Tuberculosis | Research

HIV matters when diagnosing TB in young children: an ancillary analysis in children enrolled in the INPUT stepped wedge cluster randomized study

Authors: L Powell, L Denoeud-Ndam, N Herrera, R Masaba, B Tchounga, S Siamba, M Ouma, SJ Petnga, R Machekano, B Pamen, G Okomo, L Simo, M Casenghi, N Rakhmanina, A Tiam

Published in: BMC Infectious Diseases | Issue 1/2023

Login to get access

Abstract

Background

Children under age five years, particularly those living with HIV (CLHIV), are at risk for rapid progression of tuberculosis (TB). We aimed to describe TB clinical presentations, diagnostic pathways and treatment outcomes in CLHIV compared to children without HIV in Cameroon and Kenya.

Methods

This sub-analysis of a cluster-randomized trial evaluating the integration of pediatric TB services from May 2019 to March 2021 enrolled children age < 5 years with TB. We estimated the HIV infection rate with 95% confidence interval (CI). We compared TB clinical presentations, diagnostic pathways and treatment outcomes in CLHIV and children without HIV. Finally, we investigated whether HIV infection was associated with a shorter time to TB diagnosis (≤ 3 months from symptoms onset) after adjusting for covariates. Univariable and multivariable logistic regression analysis were performed with adjusted odds ratios (AORs) presented as measures of the association of covariates with HIV status and with shorter time to TB diagnosis.

Results

We enrolled 157 children with TB (mean age was 1.5 years) and 22/157 (14.0% [9.0-20.4%]) were co-infected with HIV. CLHIV were more likely to initially present with acute malnutrition (AOR 3.16 [1.14–8.71], p = 0.027). Most TB diagnoses (140/157, 89%) were made clinically with pulmonary TB being the most common presentation; however, there was weak evidence of more frequent bacteriologic confirmation of TB in CLHIV, 18% vs. 9% (p = 0.067), due to the contribution of lateral-flow urine lipoarabinomannan to the diagnosis. HIV positivity (AOR: 6.10 [1.32–28.17], p = 0.021) was independently associated with a shorter time to TB diagnosis as well as fatigue (AOR: 6.58 [2.28–18.96], p = 0.0005), and existence of a household contact diagnosed with TB (AOR: 5.60 [1.58–19.83], p = 0.0075), whereas older age (AOR: 0.35 [0.15–0.85], p = 0.020 for age 2–5 years), night sweats (AOR: 0.24 [0.10–0.60], p = 0.0022) and acute malnutrition (AOR: 0.36 [0.14–0.92], p = 0.034) were associated with a delayed diagnosis. The case fatality rate was 9% (2/22) in CLHIV and 4% (6/135) in children without HIV, p = 0.31.

Conclusions

These results altogether advocate for better integration of TB services into all pediatric entry points with a special focus on nutrition services, and illustrate the importance of non-sputum-based TB diagnostics especially in CLHIV.

Trial registration

NCT03862261, first registration 05/03/2019.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dodd PJ, Yuen CM, Sismanidis C, Seddon JA, Jenkins HE. The global burden of tuberculosis mortality in children: a mathematical modelling study. Lancet Glob Health. 2017;5(9):e898–e906.CrossRefPubMedPubMedCentral Dodd PJ, Yuen CM, Sismanidis C, Seddon JA, Jenkins HE. The global burden of tuberculosis mortality in children: a mathematical modelling study. Lancet Glob Health. 2017;5(9):e898–e906.CrossRefPubMedPubMedCentral
2.
go back to reference World Health Organization: Global Tuberculosis Report. In. Geneva, Switzerland; 2021. World Health Organization: Global Tuberculosis Report. In. Geneva, Switzerland; 2021.
3.
go back to reference Yerramsetti S, Cohen T, Atun R, Menzies NA. Global estimates of paediatric tuberculosis incidence in 2013-19: a mathematical modelling analysis. Lancet Glob Health. 2022;10(2):e207–15.CrossRefPubMed Yerramsetti S, Cohen T, Atun R, Menzies NA. Global estimates of paediatric tuberculosis incidence in 2013-19: a mathematical modelling analysis. Lancet Glob Health. 2022;10(2):e207–15.CrossRefPubMed
4.
go back to reference World Health Organization: Roadmap towards ending TB in children and adolescents. In., Second edition edn. Geneva, Switzerland; 2018. World Health Organization: Roadmap towards ending TB in children and adolescents. In., Second edition edn. Geneva, Switzerland; 2018.
5.
go back to reference Lawn SD, Bekker LG, Wood R. How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control. AIDS. 2005;19(11):1113–24.CrossRefPubMed Lawn SD, Bekker LG, Wood R. How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control. AIDS. 2005;19(11):1113–24.CrossRefPubMed
6.
go back to reference Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PLoS ONE. 2012;7(3):e34156.CrossRefPubMedPubMedCentral Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PLoS ONE. 2012;7(3):e34156.CrossRefPubMedPubMedCentral
7.
go back to reference Dunn JJ, Starke JR, Revell PA. Laboratory diagnosis of Mycobacterium tuberculosis infection and disease in children. J Clin Microbiol. 2016;54(6):1434–41.CrossRefPubMedPubMedCentral Dunn JJ, Starke JR, Revell PA. Laboratory diagnosis of Mycobacterium tuberculosis infection and disease in children. J Clin Microbiol. 2016;54(6):1434–41.CrossRefPubMedPubMedCentral
8.
go back to reference Reid MJ, Shah NS. Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis. 2009;9(3):173–84.CrossRefPubMed Reid MJ, Shah NS. Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis. 2009;9(3):173–84.CrossRefPubMed
9.
go back to reference Shingadia D, Novelli V. Diagnosis and treatment of tuberculosis in children. Lancet Infect Dis. 2003;3(10):624–32.CrossRefPubMed Shingadia D, Novelli V. Diagnosis and treatment of tuberculosis in children. Lancet Infect Dis. 2003;3(10):624–32.CrossRefPubMed
10.
go back to reference Hesseling AC, Schaaf HS, Gie RP, Starke JR, Beyers N. A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis. Int J Tuberc Lung Dis. 2002;6(12):1038–45.PubMed Hesseling AC, Schaaf HS, Gie RP, Starke JR, Beyers N. A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis. Int J Tuberc Lung Dis. 2002;6(12):1038–45.PubMed
12.
go back to reference Horne DJ, Kohli M, Zifodya JS, Schiller I, Dendukuri N, Tollefson D, Schumacher SG, Ochodo EA, Pai M, Steingart KR. Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2019;6:CD009593.PubMed Horne DJ, Kohli M, Zifodya JS, Schiller I, Dendukuri N, Tollefson D, Schumacher SG, Ochodo EA, Pai M, Steingart KR. Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2019;6:CD009593.PubMed
13.
go back to reference Kohli M, Schiller I, Dendukuri N, Yao M, Dheda K, Denkinger CM, Schumacher SG, Steingart KR. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2021;1:CD012768.PubMed Kohli M, Schiller I, Dendukuri N, Yao M, Dheda K, Denkinger CM, Schumacher SG, Steingart KR. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2021;1:CD012768.PubMed
14.
go back to reference Dorman SE, Schumacher SG, Alland D, Nabeta P, Armstrong DT, King B, Hall SL, Chakravorty S, Cirillo DM, Tukvadze N, et al. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. 2018;18(1):76–84.CrossRefPubMedPubMedCentral Dorman SE, Schumacher SG, Alland D, Nabeta P, Armstrong DT, King B, Hall SL, Chakravorty S, Cirillo DM, Tukvadze N, et al. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. 2018;18(1):76–84.CrossRefPubMedPubMedCentral
15.
go back to reference Haraka F, Kakolwa M, Schumacher SG, Nathavitharana RR, Denkinger CM, Gagneux S, Reither K, Ross A. Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis. Cochrane Database Syst Rev. 2021;5:CD012972.PubMed Haraka F, Kakolwa M, Schumacher SG, Nathavitharana RR, Denkinger CM, Gagneux S, Reither K, Ross A. Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis. Cochrane Database Syst Rev. 2021;5:CD012972.PubMed
16.
go back to reference Bjerrum S, Schiller I, Dendukuri N, Kohli M, Nathavitharana RR, Zwerling AA, Denkinger CM, Steingart KR, Shah M. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV. Cochrane Database Syst Rev. 2019;10:CD011420.PubMed Bjerrum S, Schiller I, Dendukuri N, Kohli M, Nathavitharana RR, Zwerling AA, Denkinger CM, Steingart KR, Shah M. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV. Cochrane Database Syst Rev. 2019;10:CD011420.PubMed
17.
go back to reference Gupta-Wright A, Peters JA, Flach C, Lawn SD. Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-saharan Africa: a systematic review and meta-analysis. BMC Med. 2016;14:53.CrossRefPubMedPubMedCentral Gupta-Wright A, Peters JA, Flach C, Lawn SD. Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-saharan Africa: a systematic review and meta-analysis. BMC Med. 2016;14:53.CrossRefPubMedPubMedCentral
18.
go back to reference World Health Organization: WHO consolidated guidelines on tuberculosis. Module 5: Management of tuberculosis in children and adolescents. In, Geneva. Switzerland; 2022. World Health Organization: WHO consolidated guidelines on tuberculosis. Module 5: Management of tuberculosis in children and adolescents. In, Geneva. Switzerland; 2022.
19.
go back to reference Denoeud-Ndam L, Otieno-Masaba R, Tchounga B, Machekano R, Simo L, Mboya JP, Kose J, Tchendjou P, Bissek AZ, Okomo GO, et al. Integrating pediatric TB services into child healthcare services in Africa: study protocol for the INPUT cluster-randomized stepped wedge trial. BMC Public Health. 2020;20(1):623.CrossRefPubMedPubMedCentral Denoeud-Ndam L, Otieno-Masaba R, Tchounga B, Machekano R, Simo L, Mboya JP, Kose J, Tchendjou P, Bissek AZ, Okomo GO, et al. Integrating pediatric TB services into child healthcare services in Africa: study protocol for the INPUT cluster-randomized stepped wedge trial. BMC Public Health. 2020;20(1):623.CrossRefPubMedPubMedCentral
20.
go back to reference World Health Organization: Definitions and Reporting Framework for Tuberculosis – 2013 Revision In. Geneva, Switzerland; 2013. World Health Organization: Definitions and Reporting Framework for Tuberculosis – 2013 Revision In. Geneva, Switzerland; 2013.
21.
go back to reference Cavanaugh J, Genga K, Marigu I, Laserson K, Ackers M, Cain K. Tuberculosis among children in Kenya: epidemiology and impact of HIV in two provinces. J Trop Pediatr. 2012;58(4):292–6.CrossRefPubMed Cavanaugh J, Genga K, Marigu I, Laserson K, Ackers M, Cain K. Tuberculosis among children in Kenya: epidemiology and impact of HIV in two provinces. J Trop Pediatr. 2012;58(4):292–6.CrossRefPubMed
22.
go back to reference Mbatchou Ngahane BH, Dahirou F, Tchieche C, Wandji A, Ngnie C, Nana-Metchedjin A, Nyankiye E, Endale Mangamba ML, Kuaban C. Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study. Int J Tuberc Lung Dis. 2016;20(12):1609–14.CrossRefPubMed Mbatchou Ngahane BH, Dahirou F, Tchieche C, Wandji A, Ngnie C, Nana-Metchedjin A, Nyankiye E, Endale Mangamba ML, Kuaban C. Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study. Int J Tuberc Lung Dis. 2016;20(12):1609–14.CrossRefPubMed
23.
go back to reference Jenkins HE, Yuen CM, Rodriguez CA, Nathavitharana RR, McLaughlin MM, Donald P, Marais BJ, Becerra MC. Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(3):285–95.CrossRefPubMed Jenkins HE, Yuen CM, Rodriguez CA, Nathavitharana RR, McLaughlin MM, Donald P, Marais BJ, Becerra MC. Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(3):285–95.CrossRefPubMed
24.
go back to reference Moon TD, Nacarapa E, Verdu ME, Macuacua S, Mugabe D, Gong W, Carlucci JG, Ramos JM, Valverde E. Tuberculosis treatment outcomes among children in Rural Southern Mozambique: a 12-year Retrospective Study. Pediatr Infect Dis J. 2019;38(10):999–1004.CrossRefPubMedPubMedCentral Moon TD, Nacarapa E, Verdu ME, Macuacua S, Mugabe D, Gong W, Carlucci JG, Ramos JM, Valverde E. Tuberculosis treatment outcomes among children in Rural Southern Mozambique: a 12-year Retrospective Study. Pediatr Infect Dis J. 2019;38(10):999–1004.CrossRefPubMedPubMedCentral
25.
go back to reference Mukuku O, Mutombo AM, Kakisingi CN, Musung JM, Wembonyama SO, Luboya ON. Tuberculosis and HIV co-infection in congolese children: risk factors of death. Pan Afr Med J. 2019;33:326.CrossRefPubMedPubMedCentral Mukuku O, Mutombo AM, Kakisingi CN, Musung JM, Wembonyama SO, Luboya ON. Tuberculosis and HIV co-infection in congolese children: risk factors of death. Pan Afr Med J. 2019;33:326.CrossRefPubMedPubMedCentral
26.
go back to reference Munthali T, Chabala C, Chama E, Mugode R, Kapata N, Musonda P, Michelo C. Tuberculosis caseload in children with severe acute malnutrition related with high hospital based mortality in Lusaka, Zambia. BMC Res Notes. 2017;10(1):206.CrossRefPubMedPubMedCentral Munthali T, Chabala C, Chama E, Mugode R, Kapata N, Musonda P, Michelo C. Tuberculosis caseload in children with severe acute malnutrition related with high hospital based mortality in Lusaka, Zambia. BMC Res Notes. 2017;10(1):206.CrossRefPubMedPubMedCentral
27.
go back to reference Golub JE, Bur S, Cronin WA, Gange S, Baruch N, Comstock GW, Chaisson RE. Delayed tuberculosis diagnosis and tuberculosis transmission. Int J Tuberc Lung Dis. 2006;10(1):24–30.PubMed Golub JE, Bur S, Cronin WA, Gange S, Baruch N, Comstock GW, Chaisson RE. Delayed tuberculosis diagnosis and tuberculosis transmission. Int J Tuberc Lung Dis. 2006;10(1):24–30.PubMed
28.
go back to reference Pablos-Mendez A, Sterling TR, Frieden TR. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA. 1996;276(15):1223–8.CrossRefPubMed Pablos-Mendez A, Sterling TR, Frieden TR. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA. 1996;276(15):1223–8.CrossRefPubMed
29.
go back to reference Virenfeldt J, Rudolf F, Camara C, Furtado A, Gomes V, Aaby P, Petersen E, Wejse C. Treatment delay affects clinical severity of tuberculosis: a longitudinal cohort study. BMJ Open. 2014;4(6):e004818.CrossRefPubMedPubMedCentral Virenfeldt J, Rudolf F, Camara C, Furtado A, Gomes V, Aaby P, Petersen E, Wejse C. Treatment delay affects clinical severity of tuberculosis: a longitudinal cohort study. BMJ Open. 2014;4(6):e004818.CrossRefPubMedPubMedCentral
30.
go back to reference Palme IB, Gudetta B, Bruchfeld J, Muhe L, Giesecke J. Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of ethiopian children with tuberculosis. Pediatr Infect Dis J. 2002;21(11):1053–61.CrossRefPubMed Palme IB, Gudetta B, Bruchfeld J, Muhe L, Giesecke J. Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of ethiopian children with tuberculosis. Pediatr Infect Dis J. 2002;21(11):1053–61.CrossRefPubMed
31.
go back to reference Getnet F, Demissie M, Assefa N, Mengistie B, Worku A. Delay in diagnosis of pulmonary tuberculosis in low-and middle-income settings: systematic review and meta-analysis. BMC Pulm Med. 2017;17(1):202.CrossRefPubMedPubMedCentral Getnet F, Demissie M, Assefa N, Mengistie B, Worku A. Delay in diagnosis of pulmonary tuberculosis in low-and middle-income settings: systematic review and meta-analysis. BMC Pulm Med. 2017;17(1):202.CrossRefPubMedPubMedCentral
33.
go back to reference Zachariah R, Spielmann MP, Harries AD, Salaniponi FM. Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death. Trans R Soc Trop Med Hyg. 2002;96(3):291–4.CrossRefPubMed Zachariah R, Spielmann MP, Harries AD, Salaniponi FM. Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death. Trans R Soc Trop Med Hyg. 2002;96(3):291–4.CrossRefPubMed
34.
go back to reference Bhat PG, Kumar AM, Naik B, Satyanarayana S, Kg D, Nair SA, Md S, Heldal E, Enarson DA, Reid AJ. Intensified tuberculosis case finding among malnourished children in nutritional rehabilitation centres of Karnataka, India: missed opportunities. PLoS ONE. 2013;8(12):e84255.CrossRefPubMedPubMedCentral Bhat PG, Kumar AM, Naik B, Satyanarayana S, Kg D, Nair SA, Md S, Heldal E, Enarson DA, Reid AJ. Intensified tuberculosis case finding among malnourished children in nutritional rehabilitation centres of Karnataka, India: missed opportunities. PLoS ONE. 2013;8(12):e84255.CrossRefPubMedPubMedCentral
35.
go back to reference Andama A, Jaganath D, Crowder R, Asege L, Nakaye M, Katumba D, Mwebe S, Semitala F, Worodria W, Joloba M, et al. Accuracy and incremental yield of urine Xpert MTB/RIF Ultra versus Determine TB-LAM for diagnosis of pulmonary tuberculosis. Diagn Microbiol Infect Dis. 2020;96(1):114892.CrossRefPubMed Andama A, Jaganath D, Crowder R, Asege L, Nakaye M, Katumba D, Mwebe S, Semitala F, Worodria W, Joloba M, et al. Accuracy and incremental yield of urine Xpert MTB/RIF Ultra versus Determine TB-LAM for diagnosis of pulmonary tuberculosis. Diagn Microbiol Infect Dis. 2020;96(1):114892.CrossRefPubMed
36.
go back to reference LaCourse SM, Pavlinac PB, Cranmer LM, Njuguna IN, Mugo C, Gatimu J, Stern J, Walson JL, Maleche-Obimbo E, Oyugi J, et al. Stool Xpert MTB/RIF and urine lipoarabinomannan for the diagnosis of tuberculosis in hospitalized HIV-infected children. AIDS. 2018;32(1):69–78.CrossRefPubMed LaCourse SM, Pavlinac PB, Cranmer LM, Njuguna IN, Mugo C, Gatimu J, Stern J, Walson JL, Maleche-Obimbo E, Oyugi J, et al. Stool Xpert MTB/RIF and urine lipoarabinomannan for the diagnosis of tuberculosis in hospitalized HIV-infected children. AIDS. 2018;32(1):69–78.CrossRefPubMed
Metadata
Title
HIV matters when diagnosing TB in young children: an ancillary analysis in children enrolled in the INPUT stepped wedge cluster randomized study
Authors
L Powell
L Denoeud-Ndam
N Herrera
R Masaba
B Tchounga
S Siamba
M Ouma
SJ Petnga
R Machekano
B Pamen
G Okomo
L Simo
M Casenghi
N Rakhmanina
A Tiam
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2023
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-023-08216-w

Other articles of this Issue 1/2023

BMC Infectious Diseases 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine